Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iyas Hamwi

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Medizinische Monatsschrift Fur Pharmazeuten|December 6, 2008
[Protective use of calcium in case of osteoporosis versus calcium oxalate stones]Iyas Hamwi, Dirk O Stichtenoth, Gesine Picksak
Medizinische Monatsschrift Fur Pharmazeuten|July 30, 2008
[Accidental acetaminophen overdose]Iyas Hamwi, Gesine Picksak, Dirk O Stichtenoth
BMC Nephrology|August 25, 2010
Biopsy proven acute interstitial nephritis after treatment with moxifloxacinChristos Chatzikyrkou, Iyas Hamwi, Christian Clajus, et al.
Immunological Investigations|October 23, 2012
Reconstitution and phenotype of Tregs in CMV reactivating patients following allogeneic hematopoietic stem cell transplantationSarvari Velaga, Sya N Ukena, Matthias Höpting, et al.
Annals of Hematology|July 25, 2023
The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host diseaseMichael Stadler, Lothar Hambach, Elke Dammann, et al.
Blood|March 5, 2011
Integrative prognostic risk score in acute myeloid leukemia with normal karyotypeFrederik Damm, Michael Heuser, Michael Morgan, et al.
Cancer Cell|July 12, 2011
Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1/AbdB-like HOX protein complexMichael Heuser, Haiyang Yun, Tobias Berg, et al.
Blood|September 8, 2018
Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AMLFelicitas Thol, Razif Gabdoulline, Alessandro Liebich, et al.
Leukemia|October 21, 2020
A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapyEva M Weissinger, Jochen Metzger, Michael Schleuning, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Medizinische Monatsschrift Fur Pharmazeuten|December 6, 2008
[Protective use of calcium in case of osteoporosis versus calcium oxalate stones]Iyas Hamwi, Dirk O Stichtenoth, Gesine Picksak
Medizinische Monatsschrift Fur Pharmazeuten|July 30, 2008
[Accidental acetaminophen overdose]Iyas Hamwi, Gesine Picksak, Dirk O Stichtenoth
BMC Nephrology|August 25, 2010
Biopsy proven acute interstitial nephritis after treatment with moxifloxacinChristos Chatzikyrkou, Iyas Hamwi, Christian Clajus, et al.
Immunological Investigations|October 23, 2012
Reconstitution and phenotype of Tregs in CMV reactivating patients following allogeneic hematopoietic stem cell transplantationSarvari Velaga, Sya N Ukena, Matthias Höpting, et al.
Annals of Hematology|July 25, 2023
The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host diseaseMichael Stadler, Lothar Hambach, Elke Dammann, et al.
Blood|March 5, 2011
Integrative prognostic risk score in acute myeloid leukemia with normal karyotypeFrederik Damm, Michael Heuser, Michael Morgan, et al.
Cancer Cell|July 12, 2011
Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1/AbdB-like HOX protein complexMichael Heuser, Haiyang Yun, Tobias Berg, et al.
Blood|September 8, 2018
Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AMLFelicitas Thol, Razif Gabdoulline, Alessandro Liebich, et al.
Leukemia|October 21, 2020
A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapyEva M Weissinger, Jochen Metzger, Michael Schleuning, et al.
Pageof 1